TABLE 1.
Summary of patient characteristics
| Variables | ||
|---|---|---|
| Sex | Male/female, n (%) | 12/7 (63.2/36.8) |
| Age, years | Median (range), years | 56.0 (25–71) |
| BMI | Median (range) | 23.7 (14.8–32.5) |
| ≧30 | 2 (10.5) | |
| Smoking status | Never/ex‐ or current, n (%) | 8/11 (42.1/57.9) |
| Vaccine | With/without, n (%) | 4/15 (21.1/78.9) |
| Medications | Remdesivir, n (%) | 19 (100) |
| Dexamethasone, n (%) | 12 (63.2) | |
| Baricitinib, n (%) | 5 (26.3) | |
| Tocilizumab, n (%) | 4 (21.1) | |
| Anticoagulant therapy, n (%) | 9 (47.4) | |
| Others, n (%) | 1 (5.3) | |
| Prone positioning | Performed completely, n (%) | 16 (84.2) |
| Possible to continue to perform, n (%) | 13 (68.4) | |
| Mean daily duration (range), min | 214.1 ± 92.5 (78.0–444.0) | |
| Effectiveness | Mean duration of oxygen therapy (range), days | 4.8 ± 4.5 (1–15) |
| Intubation rate at day 28 (%) | 0 | |
| Mortality at day 28 (%) | 0 | |
| Adverse events | Any, n (%) | 16 (84.2) |
| Backache, n (%) | 7 (36.8) | |
| Liver dysfunction, n (%) | 7 (36.8) | |
| Stiff shoulders, n (%) | 6 (31.6) | |
| Neck pain, n (%) | 5 (26.3) | |
| Headache, n (%) | 2 (10.5) | |
| Loss of appetite, n (%) | 2 (10.5) | |
| Food reflux, n (%) | 2 (10.5) | |
| Diarrhoea, n (%) | 2 (10.5) | |
| Constipation, n (%) | 2 (10.5) | |
| Numbness, n (%) | 2 (10.5) | |
| Malaise, n (%) | 2 (10.5) |